Divalproex Sodium
NDC 87441-027, Divalproex Sodium, tablet, delayed release, from Unit Dose Solutions, Inc..
- Product NDC
- 87441-027
- Status
- Listed
- Labeler
- Unit Dose Solutions, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079163
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87441-027 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIVALPROEX SODIUM250 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87441-027-01 | 87441002701 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (87441-027-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/547d8305-bfc5-f4da-e063-6294a90a6106
Use it
Look up 87441-027 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87441-027 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87441-027. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.